• Citer

Surrogacy of Pathologic Complete Response in Trials of Neoadjuvant Therapy for Early Breast Cancer: Critical Analysis of Strengths, Weaknesses, and Misinterpretations

par Conforti, Fabio;Pala, Laura;Bagnardi, Vincenzo;De Pas, Tommaso;Colleoni, Marco Angelo;Buyse, Marc;Hortobagyi, Gabriel N.;Gianni, Luca;Winer, Eric;Loibl, Sibylle;Cortes, Javier;Piccart-Gebhart, Martine ;Wolff, Antonio C;Viale, Giuseppe;Gelber, Richard
Référence JAMA oncology, 8, 11, page (1668-1675)
Publication Publié, 2022-11

Article révisé par les pairs

• Détails
• Contenu

Titre:	Surrogacy of Pathologic Complete Response in Trials of Neoadjuvant Therapy for Early Breast Cancer: Critical Analysis of Strengths, Weaknesses, and Misinterpretations
Auteur:	Conforti, Fabio; Pala, Laura; Bagnardi, Vincenzo; De Pas, Tommaso; Colleoni, Marco Angelo; Buyse, Marc; Hortobagyi, Gabriel N.; Gianni, Luca; Winer, Eric; Loibl, Sibylle; Cortes, Javier; Piccart-Gebhart, Martine; Wolff, Antonio C; Viale, Giuseppe; Gelber, Richard
Informations sur la publication:	JAMA oncology, 8, 11, page (1668-1675)
Statut de publication:	Publié, 2022-11
Sujet CREF:	Cancérologie
Note générale:	SCOPUS: re.j
	DecretOANoAutActif
Langue:	Anglais
Identificateurs:	urn:issn:2374-2437
	info:doi/10.1001/jamaoncol.2022.3755
	info:scp/85140086369
	info:pmid/36201176